X4 Pharmaceuticals Company
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2014
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
12
Total Funding:
119499999
Estimated Revenue:
Less than $1M
Last Funding Date:
2021
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership